REGULATORY & COMPLIANCE

THE ONLY PROVEN AND PATENTED BETA-ALANINE

17 GLOBAL PATENTS

Backed by years of scientific research, CarnoSyn® is the only patented beta-alanine on the market.

CarnoSyn® is the only beta-alanine imported and sold in the U.S. licensed under NAI’s growing portfolio of U.S. and foreign patents. Ultimately, this ensures that any future advancements in sports nutrition research and technology related to beta-alanine will continue to benefit athletes around the world. Current patents issued globally include:

patent US flag
USA
9 patents
    Patent CANADA flag
    CANADA
    1 patent
      Patent S KOREA flag
      S. KOREA
      2 patents
        Patent JAPAN flag
        JAPAN
        1 patent
          Patent EUROPE flag
          EUROPE
          3 patents
            patent CHINA flag
            CHINA
            1 patent
              CarnoSyn beta alanine | FDA

              THE ONLY NDI-STATUS BETA-ALANINE

              In 2019, CarnoSyn® beta-alanine established New Dietary Ingredient (NDI) status. Becoming an NDI ingredient reaffirms our commitment to deliver the highest-quality solutions to athletes and brand partners, and further distinguishes CarnoSyn® from generic forms of beta-alanine with questionable quality and effectiveness.

              Read the Press Release
              CarnoSyn beta alanine gras cert

              GENERALLY RECOGNIZED AS SAFE

              With self-affirmed GRAS status, you can be confident that CarnoSyn® is a safe and effective ingredient. Self-Affirmed GRAS status allows opportunities within the dietary supplement and food & beverage industries.

              Read the Press Release
              CarnoSyn beta alanine - 55 Scientific Studies

              55+ Scientific Studies

              Over 55 clinical studies support the athletic performance benefits of CarnoSyn® beta-alanine. CarnoSyn® was proven to increase muscle carnosine and increase performance when athletes dosed with at least 3.2-6.4 grams of CarnoSyn® per day over a 28-day period.

              Get the full story